Guardant Health
GH
#1003
Rank
S$30.51 B
Marketcap
S$227.39
Share price
1.75%
Change (1 day)
180.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: S$30.51 Billion

As of October 2026 Guardant Health has a market cap of S$30.51 Billion. This makes Guardant Health the world's 1003th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$30.51 B77.71%
2025S$17.17 B235.89%
2024S$5.11 B17.89%
2023S$4.33 B16.09%
2022S$3.73 B-72.83%
2021S$13.74 B-19.36%
2020S$17.04 B72.3%
2019S$9.89 B124.64%
2018S$4.40 B

End of Day market cap according to different sources

On Oct 3rd, 2026 the market cap of Guardant Health was reported to be:

S$30.51 Billion
by Nasdaq info icon info icon
S$30.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
S$3.38 B-88.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S$75.64 B 147.90%๐Ÿ‡บ๐Ÿ‡ธ USA